Top 10 stocks that hit gold in FY18 Top 10 stocks that hit gold in FY18 Amir Shaikh / Thursday, March 29, 2018 / Article rating: 3.9 During FY18, the benchmark index Sensex has gone through various jolts, but despite this, the Sensex has delivered a 14.3 per cent growth in the fiscal year 2018.
Videocon NPA dwarfs image of ICICI Bank, Kochhar Videocon NPA dwarfs image of ICICI Bank, Kochhar Gayathri Udyawar / Thursday, March 29, 2018 / Article rating: 5.0 If the public sector banks are facing scrutiny for loans sanctioned on back of pressures from the government or influential politicians, the private banks are now under the scanner for vested interests and other such possible favoritism in granting of unworthy loans to defaulting borrowers.
Top funds with low probability of steep losses Top funds with low probability of steep losses Nikhil Desai / Wednesday, March 28, 2018 / Article rating: 5.0 With the current market volatility, it is very significant for a mutual fund investor to pick right mutual fund schemes from the range of schemes available in the market. To tackle with the market volatility, it is important to look into the risks involved in the investment of particular scheme
IDBI Bank uncovers fraud of Rs. 7.72 billion, share price falls IDBI Bank uncovers fraud of Rs. 7.72 billion, share price falls Nikita Singh / Wednesday, March 28, 2018 / Article rating: 5.0 Adding to the string of banking system frauds disclosed in the recent times, IDBI Bank announced on Tuesday that it has uncovered fraudulent loans worth Rs. 7.72 billion that were issued from five of its branches in Andhra Pradesh and Telangana.
Alkem Laboratories receives 14 USFDA observations Alkem Laboratories receives 14 USFDA observations Nikita Singh / Wednesday, March 28, 2018 / Article rating: 5.0 Pharma major Alkem Laboratories nosedived by 11 per cent on Wednesday as the US Food and Drug Administration issued 13 observations to the company’s Daman facility and one observation to its US based manufacturing unit.
EU Commission approves Semglee developed by Biocon and Mylan EU Commission approves Semglee developed by Biocon and Mylan Gayathri Udyawar / Wednesday, March 28, 2018 / Article rating: 5.0 Semglee is a biosimilar to insulin glargine and is co-developed by the two companies. The product will be offered in a 100 units/mL 3 mL prefilled disposable pen.
Does good economics mean good equity return? Does good economics mean good equity return? Shashikant Singh / Wednesday, March 28, 2018 / Article rating: 4.7 In year 2008, Indian economy grew by 8.48 per cent, however, frontline indices fell by 52 per cent. What does it tell about the relationship between equity return and economic growth? Let's understand.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Wednesday, March 28, 2018 / Article rating: 5.0 Following stocks are close to their 52-week low as at 2.22 p.m. on March 28, 2018.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Wednesday, March 28, 2018 / Article rating: 5.0 The markets on March 28, 2018 opened down. BSE Sensex is trading at 33,036.59, down by 137.80 points and the Nifty is trading at 10,142.05, down by 42.10 points.
L&T Construction bags orders worth Rs. 4,353 crore L&T Construction bags orders worth Rs. 4,353 crore Nikita Singh / Wednesday, March 28, 2018 / Article rating: 5.0 EPC major L&T Construction added another major project to its order book as the company won contracts worth Rs. 4,353 crore in the power transmission and distribution business in India as well as abroad.